Crystal structure of (1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)(4-((2-methyl-6-(trifluoromethyl)pyrimidin-4-yl)amino)piperidin-1-yl)methanone, C17H18F6N6O
C17H18F6N6O, monoclinic, P21/n (no. 14), a = 9.9491(11) Å, b = 18.1523(17) Å, c = 11.7703(15) Å, β = 113.473(14)°, V = 1949.8(4) Å3, Z = 4, Rgt(F) = 0.0606, wRref(F2) = 0.1876, T = 169.99(10) K.
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
De Gruyter
2023-10-01
|
| Saila: | Zeitschrift für Kristallographie - New Crystal Structures |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1515/ncrs-2023-0265 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|